Seeger Weiss partners lead National Prescription Opiate Litigation Plaintiffs’ Executive Committee in $26 billion global opioid settlement

Seeger Weiss founding partner Chris Seeger along with partners Jennifer Scullion and Dave Buchanan helped lead the National Prescription Opiate Litigation team that resulted in over 90 percent of litigating local governments confirming participation in global settlements with AmerisourceBergen, Cardinal Health, and McKesson, and Johnson & Johnson totaling $26 billion. The settlements require 85% of […]

March 3, 2022

Seeger Weiss founding partner Chris Seeger along with partners Jennifer Scullion and Dave Buchanan helped lead the National Prescription Opiate Litigation team that resulted in over 90 percent of litigating local governments confirming participation in global settlements with AmerisourceBergen, Cardinal Health, and McKesson, and Johnson & Johnson totaling $26 billion.

The settlements require 85% of funds be allocated to programs that will help address the ongoing opioid crisis through treatment, education, and prevention efforts. A majority of states have already passed agreements that dictate how funds will be distributed between state and local subdivision governments, ensuring funds will effectively reach communities in the coming months. The first round of funding could be delivered as soon as May 2022 following a consent judgment within each participating state. The settlement also calls for injunctive relief that requires the “Big Three” drug distributors and Johnson & Johnson to make significant changes to corporate practices to protect consumer health and welfare.

The settlement was made possible in part by the years of advocacy by the entire Plaintiffs’ Executive Committee (PEC) on behalf of their more than 3,300 community clients. This team of lawyers worked for over four years to position these cases for this unprecedented resolution and cultivated collaborative working relationships with the State Attorneys General. The Plaintiffs’ Executive Committee continues to work actively with all parties to address the unique needs of the few states and communities that have yet to sign onto the agreements.

In addition to Seeger Weiss, the PEC negotiation team also included Elizabeth Cabraser of Lieff Cabraser, Jayne Conroy of Simmons Hanly Conroy, Paul Geller of Robbins Geller, Peter Mougey of Levin Papantonio Rafferty, and Joe Rice of Motley Rice LLC. Collectively they issued the following statement on February 25, 2022 regarding the acceptance of the settlements:

“We arrived at this moment after years of work by community leaders across the country who committed themselves to seeking funds they need to combat the opioid epidemic. We must also recognize the efforts of the many attorneys general and private counsel who have relentlessly pursued long overdue opioid epidemic recovery resources on behalf of their constituents and clients. The bottom line from this news is that help is on the way for first responders and healthcare workers on the front lines of this public health crisis. While nothing can truly make whole what was lost in this country, what we can do is ensure that thousands of communities nationwide have the tools they need to prevent the opioid epidemic from taking more lives. We hope this agreement does exactly that. It is also important to remember that while this is a vital step, it is only one of the many that are necessary to put an end to this crisis. We will continue our work at the negotiation table and in court during the trials ahead to hold companies in the opioid supply chain accountable.”

The settlement is the first of its kind to administer resources directly to the state and local governments specifically for relief programs to help rebuild the devastation caused by the opioid epidemic. The settlement will distribute funds based on population adjusted for the proportionate share of the opioid epidemic impact. The share of the impact is calculated using detailed, and objective national data, including the amount of opioids shipped to the state, the number of opioid-related deaths that occurred in the state and the number of people who suffer opioid use disorder in the state.

Updated information about these settlements are available at the Plaintiffs’ Executive Committee negotiation team’s website: www.nationalopioidsettlement.com.

Related News

August 22, 2025
Fifteen Seeger Weiss Attorneys Selected For Inclusion in the 2026 Edition of The Best Lawyers in America

Seeger Weiss LLP is proud to announce that 15 of its attorneys have been selected for inclusion in the 2026 edition of The Best Lawyers in America, including in the Best Lawyers: Ones to Watch in America, and Lawyer of the Year lists. These attorneys have been celebrated for their work in mass tort and […]

Read More
August 4, 2025
Lawdragon Names Five Seeger Weiss Partners to 2025 500 Leading Global Litigators List

Lawdragon has recognized five Seeger Weiss partners—Chris Seeger, Stephen Weiss, David Buchanan, Jennifer Scullion, and Parvin Aminolroaya—in their 2025 Lawdragon 500 Leading Global Litigators list. This annual guide honors lawyers who “assiduously work to resolve disputes between nations, bring justice for human rights abuses, address financial fraud that crosses borders and unearth stashed assets.” The […]

Read More
July 31, 2025
Seeger Weiss Founding Partner Christopher Seeger Appointed Plaintiffs’ Lead Negotiation Counsel in Johnson & Johnson Talcum Powder Litigation

Seeger Weiss founding partner Christopher Seeger has been appointed Plaintiffs’ Lead Negotiation Counsel in the Johnson & Johnson Talcum Powder Litigation by the Honorable Judge Rukhsanah L. Singh of the District of New Jersey. The multidistrict litigation includes nearly 60,000 pending cases of women who developed ovarian cancer after using Johnson & Johnson’s Baby Powder, […]

Read More